(VIDEO) A gout drug with a new mechanism is showing promise in combination with existing remedies. In this interview, a leader in its progress to market tells why lesinurad could help put an undertreated disorder in a new light.
Must you regretfully miss the event of the year, the American College of Rheumatology annual meeting? Or are you planning to dive into the maelstrom of events at ACR2014? Either way, Rheumatology Network will be there to alert you to the latest and best from the conference. New this year: On-the-spot commentary from Washington DC rheumatologist Paul DeMarco MD.